AlfaGene

AlfaGene is a biotechnology company specializing in the isolation and cultivation of human adult gastrointestinal (GI) stem cells to develop novel therapeutics and diagnostics. The company's proprietary platform enables the creation of "mini-organs" or organoids that replicate the human GI tract, providing a physiologically relevant model for drug discovery and disease modeling. AlfaGene focuses on high-need areas such as inflammatory bowel disease (IBD), Barrett’s esophagus, and GI-related cancers. By leveraging its stem cell technology, the company aims to identify new drug targets and develop cell-based therapies for regenerative medicine. Their approach allows for the screening of drug-induced toxicity and the study of disease progression in a patient-specific manner.